# Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

> **NCT01539226** · NA · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 1959 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **COMBINATION_PRODUCT:** Placebo Vaginal Ring
- **COMBINATION_PRODUCT:** Dapivirine Vaginal Ring, 25 mg

## Key facts

- **NCT ID:** NCT01539226
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-27
- **Primary completion:** 2016-12-13
- **Final completion:** 2016-12-13
- **Target enrollment:** 1959 (ACTUAL)
- **Last updated:** 2022-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539226, "Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01539226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*